Eleftherios Michailidis
- Virology top 1%
- HIV Research and Treatment 17
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment 19
- Viral gastroenteritis research and epidemiology 5
- SARS-CoV-2 and COVID-19 Research 3
- Hepatology top 2%
- Hepatitis C virus research 11
- Epidemiology top 5%
- Hepatitis B Virus Studies 12
-
- Biochemical and Molecular Research 6
- CRISPR and Genetic Engineering 4
- Co-authors
- Charles M. RiceStefan G. SarafianosKaren A. KirbyMichael A. ParniakBruno MarchandKamalendra SinghHans-Heinrich HoffmannWilliam M. Schneider
- Journals
- Antimicrobial Agents and Chemotherapy (6 papers)Journal of Hepatology (4 papers)Journal of Biological Chemistry (4 papers)
- Partner nations
- United StatesJapanGreece
In The Last Decade
Eleftherios Michailidis
41 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Virology 531
- Infectious Diseases 1.2k
- Hepatology 388
- Epidemiology 726
- Business and International Management 38
Countries citing papers authored by Eleftherios Michailidis
This map shows the geographic impact of Eleftherios Michailidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleftherios Michailidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleftherios Michailidis more than expected).
Fields of papers citing papers by Eleftherios Michailidis
This network shows the impact of papers produced by Eleftherios Michailidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleftherios Michailidis. The network helps show where Eleftherios Michailidis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eleftherios Michailidis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 31 | |
| 5 | 2020 | 108 | |
| 6 | Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networksbreakdown → | 2020 | 243 |
| 7 | 2017 | 60 | |
| 8 | 2016 | 65 | |
| 9 | 2016 | 63 | |
| 10 | CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus | 2015 | 7 |
| 11 | 2015 | 31 | |
| 12 | CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virusbreakdown → | 2015 | 244 |
| 13 | 2013 | 92 | |
| 14 | 2013 | 31 | |
| 15 | 2012 | 55 | |
| 16 | 2012 | 9 | |
| 17 | 2012 | 38 | |
| 18 | 2011 | 25 | |
| 19 | 2010 | 21 | |
| 20 | 2009 | 112 |
About Eleftherios Michailidis
Eleftherios Michailidis is a scholar working on Virology, Hepatology and Infectious Diseases, having authored 46 papers that have together received 2.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (17 papers), Hepatitis B Virus Studies (12 papers), Hepatitis C virus research (11 papers), Biochemical and Molecular Research (6 papers), Viral gastroenteritis research and epidemiology (5 papers), CRISPR and Genetic Engineering (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Virology (531 citations), Infectious Diseases (1.2k citations) and Hepatology (388 citations). Eleftherios Michailidis has collaborated with scholars based in United States, Japan and Greece. Frequent co-authors include Charles M. Rice, Stefan G. Sarafianos, Karen A. Kirby, Michael A. Parniak, Bruno Marchand, Kamalendra Singh, Hans-Heinrich Hoffmann, William M. Schneider, Amir Shlomai and Eiichi Kodama. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Hepatology, Journal of Biological Chemistry, Viruses and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.